| Name
|
DOTA-(Tyr3)-Octreotate
|
| Code
|
[177943-89-4]
|
| The alias
|
DOTA-(Tyr3)-Octreotate
|
| Sequence (single letter abbreviation)
|
DOTA-fCYwKTCT (Cys & Cys bridge)
|
| Sequence (three-letter abbreviation)
|
4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH (acetate salt)(Disulfide bond)
|
| A basic description
|
A group of compounds comprising DOTA, a metal chelator that carries a radionuclide and octreotide (an octapeptide that is a potent somatostatin (SST)) analog (where DOTA is tetra-aza-cyclododecane-N N'N"N-"'-tetra-acetate).
|
| solubility
|
|
| The molecular weight
|
1435.65
|
| Chemical formula
|
C65H90N14O19S2
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
W.A.Breeman et al., Eur. J. Nucl. Med. Mol. Imaging, 30, 917 (2003)
A.Capello et al., Cancer Biother. Radiopharm., 18, 761 (2003)
M.de Jong et al., J. Nucl. Med., 46, 13S (2005)
L.Kolby et al., Br. J. Cancer, 93, 1144 (2005)
R.Valkema et al., J. Nucl. Med., 46, 83S (2005)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
(Disulfide bond)
|